These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11940039)

  • 41. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-TRP-6-LHRH. A report on 15 girls, followed after cessation of gonadotrophin suppressive therapy.
    Kauli R; Kornreich L; Laron Z
    Horm Res; 1990; 33(1):11-7. PubMed ID: 2142928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gonadotropin-releasing hormone analogues in the management of precocious puberty.
    Spiliotis BE
    Ann N Y Acad Sci; 2000; 900():429-34. PubMed ID: 10818433
    [No Abstract]   [Full Text] [Related]  

  • 43. GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome.
    Chiavaroli V; Liberati M; D'Antonio F; Masuccio F; Capanna R; Verrotti A; Chiarelli F; Mohn A
    Eur J Endocrinol; 2010 Jul; 163(1):55-62. PubMed ID: 20356934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
    Carel JC; Eugster EA; Rogol A; Ghizzoni L; Palmert MR; ; Antoniazzi F; Berenbaum S; Bourguignon JP; Chrousos GP; Coste J; Deal S; de Vries L; Foster C; Heger S; Holland J; Jahnukainen K; Juul A; Kaplowitz P; Lahlou N; Lee MM; Lee P; Merke DP; Neely EK; Oostdijk W; Phillip M; Rosenfield RL; Shulman D; Styne D; Tauber M; Wit JM
    Pediatrics; 2009 Apr; 123(4):e752-62. PubMed ID: 19332438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist.
    Oostdijk W; Hümmelink R; Odink RJ; Partsch CJ; Drop SL; Lorenzen F; Sippell WG; van der Velde EA; Schultheiss H
    Eur J Pediatr; 1990 Feb; 149(5):308-13. PubMed ID: 2138079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Growth and precocious puberty. Results of treatment by LHRH analogs].
    Chaussain JL; Hamdani K; Swaenepoel C
    Arch Fr Pediatr; 1992 Apr; 49 Suppl 1():285-6. PubMed ID: 1449381
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of gonadotropin-releasing hormone analogue on final adult height among Jordanian children with precocious puberty.
    Swaiss HH; Khawaja NM; Farahid OH; Batieha AM; Ajlouni KM
    Saudi Med J; 2017 Nov; 38(11):1101-1107. PubMed ID: 29114697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L; Pertzelan A; Weintrob N; Phillip M; Kauli R
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4127-32. PubMed ID: 11549638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central precocious puberty in girls: internal genitalia before, during, and after treatment with long-acting gonadotropin-releasing hormone analogues.
    Jensen AM; Brocks V; Holm K; Laursen EM; Müller J
    J Pediatr; 1998 Jan; 132(1):105-8. PubMed ID: 9470009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Final height in precocious puberty patients].
    Chaussain JL; Bost M; Roger M
    Arch Pediatr; 1994 Apr; 1(4):368-70. PubMed ID: 7842091
    [No Abstract]   [Full Text] [Related]  

  • 52. Central precocious puberty: current treatment options.
    Antoniazzi F; Zamboni G
    Paediatr Drugs; 2004; 6(4):211-31. PubMed ID: 15339200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
    Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
    J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth and precocious puberty.
    Chaussain JL; Couprie C; Lacaille F; Simon D; Job JC
    Acta Paediatr Scand Suppl; 1988; 347():38-43. PubMed ID: 2978196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl-Depot in children with central precocious puberty.
    Hümmelink R; Oostdijk W; Partsch CJ; Odink RJ; Drop SL; Sippell WG
    Horm Metab Res; 1992 Mar; 24(3):122-6. PubMed ID: 1533604
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty.
    Manasco PK; Pescovitz OH; Hill SC; Jones JM; Barnes KM; Hench KD; Loriaux DL; Cutler GB
    J Pediatr; 1989 Jul; 115(1):105-8. PubMed ID: 2661787
    [No Abstract]   [Full Text] [Related]  

  • 57. Precocious puberty and statural growth.
    Carel JC; Lahlou N; Roger M; Chaussain JL
    Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
    Mouat F; Hofman PL; Jefferies C; Gunn AJ; Cutfield WS
    Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One-year treatment with gonadotropin-releasing hormone analogues does not affect body mass index, insulin sensitivity or lipid profile in girls with central precocious puberty.
    Arcari AJ; Freire AV; Escobar ME; Ballerini MG; Ropelato MG; Bergadá I; Gryngarten MG
    J Pediatr Endocrinol Metab; 2019 Feb; 32(2):181-186. PubMed ID: 30699070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison between complete and incomplete suppression of the hypophyseal-gonadal axis in girls with central precocious puberty: effect on growth and prospective final height].
    Partsch CJ; Hümmelink R; Sippell WG; Oostdijk W; Odink RJ; Drop SL
    Monatsschr Kinderheilkd; 1993 Dec; 141(12):935-9. PubMed ID: 8114776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.